Changes in arachidonate metabolism were examined in mouse peritoneal macrophages incubated with tarious types of lipoproteins. Oxidized low density lipoprotein (LDL) was incorporated by macrophages and stimulated macrophage prostaglandin E2 (PGE2) and leukotriene C4 syntheses, respectively, 10.8-and 10.7-fold higher than by the control. Production of 6-keto-PGFI,, a stable metabolite of prostacyclin, was also stimulated. No stimulation was found with native LDI, which was minimally incorporated by the cells. Acetylated LDL and beta-migrating very low density lipoprotein (Ol-VLDL), though incorporated more efficiently than oxidized LDL, also had no stimulatory effect. When oxidized LDL was separated into the lipoprotein-lipid peroxide complex and free lipid peroxides, most of the stimulatory activity was found in the former fraction, indicating that stimulation of arachidonate metabolism in the cell is associated with uptake of the lipoprotein-lipid peroxide complex. These results suggest that peroxidative modification of LDL could contribute to the progression of atheroma by stimulating arachidonate metabolism during incorporation into macrophages.
Introduction
One of the initial events of atherosclerosis shown in animal experiments is the migration of circulating monocytes into the subendothelial space and their development into macrophages (1, 2) . The intimal macrophages incorporate lipids into the cell body and eventually get converted into lipid-laden foam cells, which are characteristically found in the early stage of atheroma (2, 3) . However, matured macrophages have only a limited number of classical low density lipoprotein (LDL) receptor, and take up native LDL at a very low rate, which is insufficient to cause foam cell transformation in vitro (1, 4, 5) . Therefore investigators have been attracted to other mechanisms of incorporation and metabolism of lipoproteins in macrophages. These cells have been reported to efficiently incorporate beta-migrating very low density lipoprotein (13- VLDL)' (6) and VLDL from the Watanabe heritable hyperlipidemic rabbits, an animal model for familial hypercholesterolemia (7-9) via a specific receptor, the f3-VLDL receptor. In addition, macrophages were also demonstrated to incorporate certain types of chemically modified LDL. This pathway was first shown for acetylated LDL (acetyl-LDL) and the receptor is called the acetyl-LDL receptor (4, 5) . Although the discovery of this pathway appeared to explain the paradox of macrophages in atherogenesis, a naturally occurring modified form of LDL has not yet been identified in the body. Recently oxidized LDL, in which acyl chains are peroxidized, has been reported to be efficiently taken up by macrophages at least in part by way of acetyl-LDL receptor (10) (11) (12) . Because lipid peroxidation has been suggested to be involved in atherogenesis by pathological or epidemiological investigation (13, 14) , oxidized LDL is considered as a candidate for an example of naturally occurring, modified LDL.
While foam cell transformation of macrophages has been indicated to be one ofthe key events of atheroma formation, it has not been clarified yet whether it is only a process of accumulation of the lipid-laden cells or has some pathophysiological effects on the progression of atheroma. Macrophages release various biologically active substances when they are activated by phagocytic particles such as zymosan A or inflammatory stimuli such as lipopolysaccharides (15) . Among those substances, the products derived from arachidonate metabolism have attracted increasing attention, since recent studies have indicated their close relation to atherogenesis (16) (17) (18) (19) . However, little is known yet about arachidonate metabolism during the process of receptor-mediated incorporation of lipoproteins by macrophages and foam cell transformation. Investigation on this line, therefore, would be of some value, inasmuch as it might give us a clue for determining the functional role of the foam cells as to whether they act as a promotor for atheromatous formation (20) .
In this study we incubated mouse peritoneal macrophages with lipoproteins and examined production of arachidonate metabolites with gas chromatography-mass spectrometry (GC/MS) and radioimmunoassay (RIA). We report that oxidized LDL stimulates arachidonate metabolism in macrophages during its incorporation into the cells.
Methods
Materials [5,6,8,11,12,14,15-3H(N) ]prostaglandin E2 (PGE2) (100-200 Ci/ mmol), [14,15-3H(N) ]leukotriene C4 (LTC4) Ci/mmol), [l-'4C]arachidonic acid (40-60 mCi/mmol), Na125I (17.4 Ci/mg), and an LTC4 3H-RIA kit were obtained from New England Nuclear (Boston, MA (21) and Kita et al. (7) . The peritoneal perfusates from 20-40 mice were pooled and the cells, 3-6 X 106 cells per mouse, were collected by centrifugation at 400 g at 4VC for 10 min. After being washed once with 30 ml of PBS, the cells were resuspended in the culture medium, DME containing 10% (vol/vol) FCS, penicillin (100 U/ml), and streptomycin (100 Mg/ml), at a final density of 3 X 106 cells/ml. Aliquots (1 ml) were dispersed on to plastic petri dishes (35 X 10 mm) and the cells were cultured in humidified air containing 5% CO2 at 37°C. After 2 h, each dish was washed twice with 2 ml of DME without serum to remove nonadherent cells. After the cells were cultured for another 18 h at 37°C in 1 ml ofthe culture medium, they were washed with 1 ml of DME without FCS and used for the experiment. The experiment was initiated by adding various amounts of lipoproteins or other reagents in 1 ml of the culture medium, and incubation was carried out under conditions described above for the indicated time periods. Zymosan (80 mg) was boiled for 30 min in PBS and then incubated with 4 ml of mouse serum for 30 min at 37°C. After being washed twice with PBS, zymosan was finally resuspended in 4 ml of PBS and added to the culture medium to a final concentration of 50 Ag/ml. Cytochalasin B, prepared as a stock solution of 1.0 X 10-2 M in dimethylsulfoxide (DMSO), was added to the culture medium to a final concentration of 1 X l0-4 M with lipoproteins. After the medium was removed from each dish at the end of incubation for determination of arachidonate metabolites, the cells were washed with 2 ml of PBS twice and received 1.0 ml of0.2 N NaOH. After overnight incubation, 50-il aliquots were used for measurement of protein contents with bovine serum albumin as a standard according to the methods of Lowry et al. (22) .
3T3 cells. 3T3 cells were plated at a density of9.6 X 104 cells/ml in 1 ml of DME containing 10% (vol/vol) calf serum, penicillin (100 U/ml), and streptomycin (100 Mg/ml) on plastic petri dishes (35 X 10 mm) and maintained in humidified air containing 5% CO2 at 37°C. On day 4 of culture the cells were washed with 1 ml of DME without serum, and various amounts of lipoproteins in the culture medium were added. Measurements of arachidonate metabolites and cellular protein contents were performed as described for macrophages.
Lipoproteins
Plasma was obtained from 14-d fasting Japanese white rabbits (3.0-3.5 kg) prepared with EDTA as an anticoagulant (7, 9, 23, 24) , and LDL (d = 1.019-1.063 g/ml) was isolated by ultracentrifugation (25) and dialyzed against two changes of at least 500 vol of 10 mM sodium phosphate buffer, pH 7.4, containing 150 mM NaCl. (8-VLDL was isolated from Japanese white rabbits fed a 2% cholesterol-10% corn oil diet for 14 d (7, 9). Acetyl-LDL was prepared from LDL of healthy human subjects by the method described by Basu et al. (26) . For preparation of oxidized LDL, 5.0 mg of protein from rabbit LDL was suspended in 2 ml ofPBS containing 5 MM CUS04 and was incubated at 370C for 40 h in a CO2 incubator. LDL within 14 d of isolation was used for oxidation.
For all experiments native LDL, acetyl-LDL, $l-VLDL, and oxidized LDL were filtered through a 0.45-Mm filter (Millipore Japan, Tokyo, Japan). The recovery ofprotein and lipid peroxides determined as thiobarbituric acid-reactive substances (TBARS) was 70-80% during filtration.
HPLC and electrophoresis oflipoproteins
Lipoproteins (50-100 Mg ofprotein) were applied to the gel permeation columns (TSK GEL, G500OPW + G3000SW; Toyo Soda, Tokyo, Japan) following the method described by Okazaki et al. (27) . The experimental conditions were as follows: temperature ofthe separation columns, 40C; eluent, 150 mM Tris Cl, pH 7.4; flow rate, 0.20 ml/min. Detection of peaks was carried out by measuring cholesterol in the eluate from the column by the bioreactor-type detection system with cholesterol esterase and cholesterol oxidase, which were immobilized on TSK GEL G600OPW (Toyo Soda) (28) . To the inlet ofthe bioreactor column was introduced the staining fluid composed of peroxidase, 4-aminoantipyrine, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-toluidine, and Triton X-100. Using these reagents, cholesterol can be measured by the absorbance at 550 nm of the quinone diimine dye. The experimental conditions ofthe enzymatic reactions were as follows: temperature of the reactor, 40°C; flow rate of the staining fluid; 0.1 ml/min. Recovery for lipoproteins as determined by cholesterol content was more than 95% after passage through the HPLC system.
Agarose gel electrophoresis of lipoproteins was carried out as described by Nobel (29) .
Electron microscopy oflipoproteins
Electron microscopy of negatively stained lipoproteins was performed as described by Forte et al. (30) . In brief, LDL filtered through a 0.45-Mm filter was dialyzed against 500 vol of 3 mM sodium phosphate buffer, pH 7.4 , and then mixed with the same volume of 2% sodium phosphotungstate, pH 7.2, to make the final concentration of250 ,g of protein/ml. A small aliquot of the mixture was overlayed on a Formvar-carbon-coated grid and was examined under a electron microscope (Hitachi H-7000).
Assayfor lipid peroxides
Lipid peroxide formation was estimated as TBARS using a Lipoperoxide test kit according to the methods of Heinecke et al. (12) and Yagi (31) with a slight modification. LDL (50 Mg of protein) was suspended in 1.5 ml of 150 mM NaCl, and the suspension was mixed with 0.5 ml of 20% trichloroacetic acid (TCA) and 0.5 ml of TBA reagent (0.67% TBA aqueous solution/glacial acetic acid, 1:1, vol/vol) and boiled at 95°C for 60 min. The mixture was cooled with water and shaken vigorously with 2.0 ml of n-butanol for at least 15 s. After centrifugation at 4,000 g for 10 min, the n-butanol layer was removed, and the fluorescence was measured on a Hitachi fluorescence spectrophotometer (No. 650-60, Hitachi, Tokyo, Japan) with excitation at 515 nm and emission at 550 nm. Tetramethoxypropane was used as a standard and results were expressed as nmol of malondialdehyde (MDA) equivalents.
Extraction and radioimmunoassay ofPGE2 and LTC4
At the end of the incubation, the medium was removed and applied to extraction. After [3H]PGE2 or [3H]LTC4, 3,000-4,000 cpm, was added, the samples were applied to a SEP-PAK C 18 cartridge (Waters Associates, Milford, MA) as described by Powell (32) with a slight modification. The PGE2-and LTC4-like immunoreactivities were eluted from the cartridges with ethyl acetate and methanol, respectively. The ethyl acetate fraction was evaporated and the dried residue was dissolved in 1 ml of 50 mM Tris-Cl, pH 7.4, and used for RIA (33) . The recovery of the PGE2 internal standard was 60-70%. Methanol fraction was also evaporated, and the dried residue was used for RIA with an LTC4 3H-RIA kit (34) . The recovery of the LTC4 internal standard in the final sample was 75-80%.
For thin-layer chromatography of PGE2 immunoreactivity extracted from culture medium, aliquots of the extract dissolved in ethyl acetate were applied to 20 X 20-cm silica gel plates, and the plates were developed with the solvent, ethyl acetate/acetic acid (98:2, vol/vol). After development the plate was air-dried and the silica gel between the front and the origin was evenly divided into 14 fractions. PGE2 immunoreactivity was extracted from each fraction with ethyl acetate. The extracts were evaporated with N2 and then used for RIA of PGE2. [I-14C] arachidonic acid in I ml of DME containing 10% FCS. After 18 h, the cells were washed twice with 1 ml ofDME and incubated with 1 ml ofDME containing various additions. After 6 h, the medium was collected and applied to a SEP-PAK C18 cartridge as described above. PGs were eluted with 10 ml of ethyl acetate. 8 ml of the ethyl acetate fraction was evaporated and the residue dissolved in 100 Ml of ethyl acetate was applied to the silica gel thin layer as described above. After development the plate was air-dried and the radioactivity at the PGE2 position was measured. The rest (2 ml) ofthe ethyl acetate fraction was evaporated and the dried residue was used for RIA for PGE2. 
Derivatization and GC/MS
[2H4]PGE2, PGD2, PGF2a, 6-keto-PGFa, and TxB2 (40 ng each) were added to a medium as internal standards. Extraction was performed as described above. After evaporation of ethyl acetate, methylation was carried out by treatment of a sample with diazomethane in methanol. After purification by SEP-PAK C1 8 cartridge, methyl esters were treated with a saturated solution of methoxamine hydrochloride in pyridine at 60C for 1 h. Dimethylisopropylsilyl imidazole was then added to a reaction mixture and the solution was allowed to stand at room temperature for another hour. The reaction mixture was applied on a Sephadex LH-20 Column (5 X 0.8 cm) and the final derivative was eluted with 2.8 ml of CHCl3/n-hexane/methanol, 10:10:1 (vol/ vol/vol). After evaporation the residue was dissolved in n-hexane containing 1% (vol/vol) pyridine and used for GC/MS as described by Miyazaki et al. (35) .
GC/MS was carried out with a JEOL DX 300 GC/mass spectrometer (JEOL Ltd., Tokyo) with a data processing system. The column employed was a thermostable cross-linked OV-I fused silica capillary column (25 m X 0.31 mm i.d., Hewlett Packard Co., Palo Alto, CA), and helium was used as a carrier gas with an inlet pressure of 0.4 kg/cm2. The 
Gelfiltration ofoxidized LDL
A PD-10 column (Pharmacia Fine Chemicals, Uppsala Sweden) was equilibrated with PBS at 4VC, and 2.5 mg of protein from oxidized LDL suspended in 1 ml of PBS was loaded and eluted with 20 ml of PBS. Fractions (1.0 ml) were collected and 10-and 25-,ul aliquots were used for measurement of protein contents and for TBARS assay, respectively.
Analysis ofdata
The values shown represent mean±SE and statistical significance was determined by Student's t test.
Results
Physicochemical properties of oxidized LDL. We first examined the gel permeation behavior of our preparations of oxidized LDL by using HPLC. As shown in Fig. 1 , a major peak was found at the volume of 28.5 ml, which was a position identical with that ofnative LDL. In addition, a small shoulder was found at 24.4 ml in the uprising of this major peak. Calibration of the column showed that this shoulder represents particle(s) larger than VLDL but smaller than fl-VLDL. We next examined the morphological profile of native and oxidized LDL particles under electron microscopy. As shown in Fig. 2 A, native LDL particles were uniform in size and shape. The diameter was 22±4 nm. On the other hand, as shown in Fig. 2 remnants, i.e., 90 nm (36) . These results indicate that enlargement of particles could occur during the oxidative modification of LDL. To investigate whether both the enlarged and native-sized particles were modified, we applied our preparation of oxidized LDL to agarose gel electrophoresis. As shown in Fig. 3 , almost all the protein in our oxidized LDL preparation migrated more negatively than native LDL, suggesting that not only the enlarged particle but also the particle with native-sized diameter underwent oxidative modification. Stimulation of macrophage PGE2 synthesis by oxidized LDL. As shown in Table I , TBARS content in the oxidized LDL preparation characterized above was 32.80±2.10 nmol MDA/mg protein, which was 13.7-fold higher than that in native LDL (2.41±0.32). Consistent with previous reports (1 1, 12) , our preparation of oxidized LDL was incorporated by macrophages about 10-fold more efficiently than by native LDL. We incubated macrophages with these preparations of lipoproteins and investigated the changes in arachidonate metabolism in the cells. We measured immunoreactive PGE2 (ir-PGE2) biosynthesis by macrophages during incubation with native and oxidized LDL. When macrophages were incubated with native LDL (90 ug/ml), no increase in ir-PGE2 production was detected; ir-PGE2 formations with and without LDL were 78.2±5.3 and 75.1±8.4 ng/mg cellular protein per 6 h, respectively. In contrast, when macrophages were incubated with oxidized LDL, ir-PGE2 biosynthesis was much elevated. The formation was 397.0±12.7 ng/mg cellular protein per 6 h, which was 5.3-fold higher than the control (P < 0.01). To exclude the possibility that CU2+ in the oxidized LDL fraction stimulated arachidonate metabolism, we incubated macrophages with 2 MM Cu2+ instead of oxidized LDL. No enhanced production of ir-PGE2 was observed, i.e., 76.2±4.5 ng/mg cellular protein per 6 h. When native LDL was preincubated in PBS without Cu2+, no increase in TBARS formation nor stimulatory effect on ir-PGE2 synthesis was detected. We also examined the effect of human LDL on macrophage ir-PGE2 synthesis. Oxidized human LDL (90 Mg/ml) also stimulated ir-PGE2 production to an extent similar to that of oxidized rabbit LDL, although native human LDL had no effect (data not shown). In order to assess specificity of our RIA, we added indomethacin to the culture medium and followed ir-PGE2 biosynthesis by macrophages. Formation of ir-PGE2 was completely inhibited by 10 Mg/ml indomethacin. We next subjected the medium extract to thin-layer chromatography as described in Methods. Immunoreactivity was observed only at the position identical with authentic PGE2 (data not shown).
Elevation in PGE2 biosynthesis in the cells incubated with oxidized LDL was also observed by the GC/MS analysis of cyclooxygenase metabolites, and PGE2 contents measured were comparable with those obtained by RIA (Table II) . Enhanced production was also detected in 6-keto-PGFIa, a stable metabolite of prostacyclin (PGI2), although the extent was less than that of PGE2. We also measured formation of 6-ketoPGFia with RIA and the value was comparable to that by GC/MS (data not shown). No significant stimulation was observed on synthesis of PGD2, PGF2, or thromboxane B2 (TxB2).
When macrophages were incubated with oxidized LDL, PGE2 synthesis increased in a time-dependent curve (Fig. 4 A) . PGE2 synthesis increased almost linearly within a few hours after contact and continued to increase up to 12 h. This time course was similar to that of incorporation of oxidized LDL into the cells (data not shown). As shown in Fig. 4 To examine whether the stimulation of oxidized LDL on macrophage PGE2 production was correlated with cellular injury, the cells attached to the dish were dissolved with 0.2 N NaOH at the end of incubation and the protein contents ofthe extracts were measured. In contrast to the dramatic effect on PGE2 biosynthesis, oxidized LDL caused no decrease in cellular protein contents at the end of a 6-h incubation compared with native LDL or control (80.0±13.2, 93.6±18.4, 80.6±7.7 sg per dish, respectively) ( Table I) . We also examined microscopically the appearance of the cells stained with trypan blue. Less than 1% of the total cells were stained and there was no difference between the ratio of the stained cells in culture with and without lipoproteins.
Stimulatory effect ofoxidized LDL on macrophage LTC4
synthesis. When incubated with oxidized LDL (90 ,g of protein/ml), macrophages synthesized and released LTC4 about three times more than the control culture (29.7±15.3 and 8.3±4.6 ng/mg cellular protein per 6 h, respectively). The stimulatory effect was dose dependent on protein contents of oxidized LDL; LTC4 formation at the concentration of 180 ,ug of protein/ml was 10.7-fold higher than the control, 89.5±29.5 ng/mg cellular protein per 6 h. No stimulatory effect on LTC4 synthesis was observed in native LDL (Fig. 5) .
Specificity oflipoproteins on the stimulation ofarachidonate metabolism. In order to investigate whether the stimulatory effect of oxidized LDL on arachidonate metabolism was correlated with endocytotic incorporation of the lipoproteins (Fig. 6 ).
Association ofstimulatory effect on arachidonate metabolism with the lipoprotein-lipid peroxide complex. For further elucidation of the stimulatory effect of oxidized LDL on arachidonate metabolism, oxidized LDL was applied to gel filtration as described in Methods, and elution of TBARS and protein contents were followed. As shown in Fig. 7 In order to determine whether the stimulatory action of fraction A was associated with incorporation by the cell, we incubated macrophages with cytochalasin B, an inhibitor of receptormediated incorporation of lipoproteins (37) cholesteryl oleate and reduced stimulation by fraction A on macrophage PGE2 synthesis by 91%. When macrophages were incubated with 90 jig/ml fraction A, cholesterol reacylation rates with and without cytochalasin B were 0.75 and 12.5 nmol/mg cellular protein per 6 h, respectively, and increases in macrophage PGE2 formations were 35.0 and 405.0 ng/mg cellular protein per 6 h, respectively. Cytochalasin B had no inhibitory effect on basal PGE2 formation, i.e., 90.2 jg/mg cellular protein per 6 h. To test whether stimulatory effect of fraction A was associated with the acetyl-LDL receptor-mediated endocytosis, we examined the inhibitory effect of an excessive amount ofacetyl-LDL on the degradation of fraction A by the macrophage monolayer. When the cells were incubated with 90 jig/ml 1251I-labeled fraction A and 900 jg/ml acetyl-LDL, the degradation rate was suppressed by 55%. The stimulatory effect of 90 jug/ml fraction A on PGE2 synthesis was not significantly suppressed by the addition of 900 jg/ml acetyl-LDL; PGE2 formations at the presence or absence of acetyl-LDL in these experiments were 256.5 and 267.0 ng/mg cellular protein per 6 h, respectively. However, we could not definitely exclude involvement of acetyl-LDL receptor pathway in stimulation of PGE2 formation, since acetyl-LDL at this concentration caused increase in PGE2 formation, i.e., 130.1 jg/mg cellular protein per 6 h, almost twice as the control level, i.e., 67.5 jAg/mg cellular protein per 6 h. We also examined the effect of either 100 ,ug/ml fucoidin, a specific inhibitor of acetyl-LDL receptor, or 40 ,uM chloroquine, a lysosomal inhibitor (1, 4, 5) , on the stimulation of arachidonate metabolism in the cells by fraction A. Both ofthe reagents, however, potently stimulated arachidonate metabolism by themselves.
Study on macrophages prelabeled with ['"C]arachidonate.
In order to determine the source of arachidonate released on the stimulation by oxidized LDL, we labeled the cells with [I-14C]arachidonate as described in Methods and then stimulated them with either fraction A or zymosan. When macrophages were stimulated with 90 Ag/ml fraction A, the specific radioactivity of PGE2 formed was not significantly decreased from the value in the control experiments with no additions, i.e. 1,032±299 or 1,268±425 dpm/ng PGE2 (n = 4), respectively. Nor was it different from that found in macrophages stimulated by 50 ,ug/ml zymosan A, i.e., 1,346±299 dpm/ng PGE2 (n = 4). 
Discussion
In this study we have shown that oxidized LDL was not only incorporated by macrophages but also stimulated arachidonate metabolism (Table I ). The stimulatory effect of oxidized LDL on PGE2 synthesis by macrophages occurred in both a dose-and time-dependent manner (Fig. 4, A and B) . In addition to PGE2, oxidized LDL stimulated macrophage LTC4 synthesis (Fig. 5) . Native LDL was taken up by macrophages at a very low rate and had no stimulatory effect on arachidonate metabolism (Table I , Fig. 5 ). Since the scavenger pathway in macrophages for modified LDL was revealed in vitro, LDL modification has been proposed to play an important role in atheroma formation in vivo. Oxidized LDL is now considered to be a candidate for naturally occurring modified LDL, as lipid peroxides have been suggested to be closely correlated with initiation and progression of atheroma (14) . Peroxidized lipids have been demonstrated to accumulate in atherosclerotic lesions (13) and to cause injuries on the vascular tissues (38) . Quinn et al. have reported that oxidized LDL has inhibitory effect on the endothelial cell-derived chemotactic activity for mouse peritoneal macrophages (39) . In addition, Parthasarathy et al. (40) have also reported that probucol, a known inhibitor ofboth progression of atherosclerotic lesion and xanthoma formation (41) In our study we have demonstrated that major stimulatory activity on arachidonate metabolism exists in the lipoproteinlipid peroxide complex, and not in free lipid peroxides (Fig. 8 ). Steinberg and his collaborators reported that peroxidation of LDL is accompanied with degradation ofphosphatidylcholine into lysophosphatidylcholine and suggested possible release of free fatty acids (1 1, 47) . Since FCS is known to trap free fatty acids in the medium, we examined the stimulatory effect of fraction B in DME without FCS. Our results, however, showed that the stimulatory effect of fraction B on arachidonate metabolism was not enhanced under these conditions. Thus it is hardly possible that unsaturated fatty acids liberated from phospholipids of LDL during its peroxidation should participate as substrate for prostaglandin or leukotriene cascade.
In this study we have also shown that some of oxidized LDL particles could become enlarged severalfold in diameter (Figs. 1, 2, A Macrophages are known to release arachidonate metabolites when activated by phagocytic stimuli (50) (51) (52) (53) . In this situation, cytochalasin B augments prostaglandin synthesis by macrophages stimulated by the particles, although it inhibits phagocytotic incorporation of phagocytosed particles (54, 55) . These observations are contrary to our results. In our experiments, cytochalasin B suppressed both incorporation of oxidized LDL and stimulation of PGE2 synthesis by the cell. Moreover, stimulation of macrophage arachidonate metabolism by phagocytosis reaches plateau within 1 h after the stimuli (56), while in our experiments release of arachidonate metabolite from the cell increased gradually and continued to increase up to 12 h after contact. This time course was similar to that of incorporation of oxidized LDL by the cells. These findings suggest that the process through which oxidized LDL stimulated macrophage arachidonate metabolism is distinct from that with phagocytosis and that receptor-mediated incorporation of lipoprotein particle could be prerequisite for the stimulatory effect.
What was noteworthy in our study was that acetyl-LDL and fl-VLDL, both of which were incorporated by macrophages by receptor-mediated endocytosis more efficiently than oxidized LDL, had little stimulatory effect on arachidonate metabolism (Fig. 6 ). These results indicate that the receptormediated endocytosis of lipoprotein particle in general is not associated with activation of macrophage arachidonate metabolism. Inasmuch as acetyl-LDL and fl-VLDL had no increased TBARS contents (Fig. 6) Fig. 9 . Such a mechanism appears to be restricted to macrophages, since oxidized LDL failed to stimulate 3T3 cells to synthesize PGE2-PGE2, among the products of arachidonate metabolism, has been known to have the most active proinflammatory effects especially in the early stage, such as extensive vasodilation, enhancement of vasopermeability, and potentiation of pain caused by bradykinin or histamine (53) . In contrast, LTC4 is recognized as a potent vasoconstrictor for arteries and is known to induce an increase in vascular permeability, inducing plasma exudation (59). In addition to the effects on PGs LTs inflammatory response, a growing body of evidence indicates that lipoxygenase products play a role as a promotor of atheromatous formation (59-61). Once these events could take place in arterial walls, they would induce infiltration of more amounts of plasma LDL into the subendothelial space and facilitate the vascular injury, eventually leading further to vasospasm and progression of atheroma.
These findings indicate that oxidized LDL could induce progression of atheroma by stimulating arachidonate metabolism in macrophages. These events could occur in the body, since several lines ofevidence indicate that oxidized LDL may be an analogue for the lipoproteins accumulated in the vessel walls. Our results would be of importance in elucidating the role of macrophages and the modification of LDL in atherogenesis.
